Share
Figure 1
Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal
Format
JPEGSource
Nexalin Technology, Inc.Downloads
About Us
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases, financial disclosures and multimedia content to media, investors, and consumers worldwide.
© 2025 Digital Media Innovations, LLC. All rights reserved.